ARSENICUM TRIOXIDUM 2mg/ml * 6 ml - Pharmaceutical Supply

This tender concerns the procurement of 'ARSENICUM TRIOXIDUM CONC. PT. SOL. PERF. 2mg/ml * 6 ml'. This refers to Arsenic Trioxide, presented as a concentrate for solution for infusion, with a concentration of 2mg/ml and a volume of 6 ml per container. Arsenic Trioxide is a medication primarily used in the treatment of certain types of leukemia, particularly acute promyelocytic leukemia (APL). The tender is likely issued by a hospital, clinic, or public health authority requiring this specific pharmaceutical product. The precise concentration and volume are critical specifications. Potential bidders must ensure their offered product meets all quality standards, regulatory requirements, and the specific technical details outlined in the tender documentation, including packaging, labeling, storage, and delivery protocols.

This is a supplies contract in the health and medical services sector, with a focus on Primary Healthcare, Hospitals and Pharmaceuticals. Located in Romania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.